Nexletol (bempedoic acid) / Otsuka, Esperion Therap, Daiichi Sankyo  >>  Phase 4
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Nexletol (bempedoic acid) / Esperion Therap
NCT06431763: A Study to Investigate LDL-cholesterol Lowering With Inclisiran Compared to Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease.

Recruiting
4
400
Europe
Inclisiran sodium, PCSK9 inhibitor, siRNA, BPA, small molecule, ACL inhibitor
Novartis Pharmaceuticals
Hypercholesterolemia
09/25
09/25

Download Options